Hyperoxaluria
Template:Infobox medical condition (new) Hyperoxaluria is an excessive urinary excretion of oxalate. Individuals with hyperoxaluria often have calcium oxalate kidney stones. It is sometimes called Bird's disease, after Golding Bird, who first described the condition.
Presentation
Causes
Hyperoxaluria can be primary (as a result of a genetic defect) or secondary to another disease process.Script error: No such module "Unsubst".
Type I primary hyperoxaluria (PH1) is associated mutations in the gene encoding AGXT, a key enzyme involved in oxalate metabolism. PH1 is an example of a protein mistargeting disease, wherein AGXT shows a trafficking defect. Instead of being trafficked to peroxisomes, it is targeted to mitochondria, where it is metabolically deficient despite being catalytically active. Type II is associated with GRHPR.[1]
Secondary hyperoxaluria can occur as a complication of jejunoileal bypass, or in a patient who has lost much of the ileum with an intact colon. In these cases, hyperoxaluria is caused by excessive gastrointestinal oxalate absorption.[2]
Excessive intake of oxalate-containing food, such as rhubarb, may also be a cause in rare cases.[3]
Diagnosis
Types
The types are the following:Script error: No such module "Unsubst".
- Primary hyperoxaluria
- Enteric hyperoxaluria
- Idiopathic hyperoxaluria
- Oxalate poisoning
Treatment
The main therapeutic approach to primary hyperoxaluria is still restricted to symptomatic treatment, i.e. kidney transplantation once the disease has already reached mature or terminal stages. However, through genomics and proteomics approaches, efforts are currently being made to elucidate the kinetics of AGXT folding which has a direct bearing on its targeting to appropriate subcellular localization. A child with primary hyperoxaluria was treated with a liver and kidney transplant.[4] A favorable outcome is more likely if a kidney transplant is complemented by a liver transplant, given the disease originates in the liver.Script error: No such module "Unsubst".
Secondary hyperoxaluria is much more common than primary hyperoxaluria, and should be treated by limiting dietary oxalate and providing calcium supplementation.Script error: No such module "Unsubst".
LDHA inhibitors (such as CHK-336) have been evaluated in clinical trials for treatment of primary hyperoxaluria, though none have been approved as of 2025.[5]
References
<templatestyles src="Reflist/styles.css" />
Script error: No such module "Check for unknown parameters".
External links
Script error: No such module "Navbox". Template:Abnormal clinical and laboratory findings for urine